Advertisement

Zymogen Protein C Concentrate for Safer Heterozygote Surgery, “I am a Guinea Pig!”

  • Duane Frederick Bruley
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 645)

Abstract

Of great concern in medical surgery is the formation of blood clots, such as, deep vein thrombosis (DVT) with possible emboli reaching the lungs, thus diminishing or shutting down the oxygen transport to tissue processes. Our research has focused on producing an inexpensive protein C product via IMAC that could be used to bring blood levels to normal. Our work has emphasized safety for hereditary and acquired protein C deficient patients in all aspects of life. There are presently two expensive protein C products on the market. One is Xigris (activated protein C) produced by Eli Lilly & Co., and the second is Ceprotin, the zymogen product which is being manufactured by Baxter BioPharmaceuticals. I will be a guinea pig for my own research hypothesis in that I will have total hip replacement surgery using Ceprotin to help prevent blood clotting due to a protein C deficiency. It is difficult for surgeons and hematologists to agree on a safe procedure for protein C deficient patients undergoing major surgery. The hematologist is concerned about the potential for DVT and lung emboli, while the surgeon is also concerned about internal bleeding and infection after the surgery. The established approach would involve high doses of low molecular weight heparin (LMWH) for protein C deficient patients which would be unacceptable to the surgeon. My hypothesis has recommended administration of zymogen protein C to simulate a normal blood condition where the standard protocol could be used. The validity of this hypothesis is soon to be tested.

Keywords

Deep Vein Thrombosis Tissue Plasminogen Activator Immobilize Metal Affinity Chromatography Deficient Patient Serine Protease Domain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    H.I. Bicher., Bruley, D. F., and M. H. Knisely, “Anti-Adhesive Drugs and Tissue Oxygenation,” edited by D. F. Bruley and H. I. Bicher, Advances in Experimental Medicine and Biology, Plenum, Press, Vol. 37B657-667, 1973.Google Scholar
  2. 2.
    D.F.Bruley. and W. N. Drohan, “Protein C and Related Anticoagulants,” Advances in Applied Biotechnology Series, Volume 11, Gulf Publishing Company (Portfolio Publishing Company), 1990.Google Scholar
  3. 3.
    G.R. Sharma., Gerlitz, G., Berg, D.T., Cramer, M.S., Jakubowski, J.A., Galbreath, E.J., Heuer, J.G., and B.W.Grinnell, “Activated Protein C Modulates Chemokine Response, and Tissue Injuiry in Expereimental Sepsis”, Advances in Experimental Medicine and Biology, Vol. 614, pp.83-91, Springer, 2008.PubMedCrossRefGoogle Scholar
  4. 4.
    D.F.Bruley, Hereditary protein C deficiency, ENCH 444 Class Handout, 1996.Google Scholar
  5. 5.
    P.C.Comp., “The clinical potential of protein C and activated protein C, advances in applied biotechnology series: protein C and related anticoagulants,” edited by D. F. Bruley and W. Drohan (Portfolio Publ. Co., Texas, 1990), vol. 11.Google Scholar
  6. 6.
    D.F.Bruley, Hereditary protein C deficiency, ENCH 444 Class Handout, 1996.Google Scholar
  7. 7.
    R.Drews., et al., Proteolytic maturation of protein C upon engineering the mouse mammary gland to express furin, Proc. Natl. Acad. Sci. USA 92, 10462 (1995).Google Scholar
  8. 8.
    D.B.McClure., et al., Post-translational processing events in the secretion pathway of human protein C, a complex vitamin K-dependent antithrombotic factor, J. Bio. Chem. 267(27), 19710 (1992).Google Scholar
  9. 9.
    C.T.Esmon., The roles of protein C and thrombomodulin in the regulation of blood coagulation, J. Bio. Chem. 264 (9), 4743 (1989).Google Scholar
  10. 10.
    C.M.Henkens., et al., Plasma levels of protein S., protein C, and factor X; Effects of sex, hormonal state and age, Thrombosis and Haemostasis 74 (1995).Google Scholar
  11. 11.
    T.Mather., et al., The 2.8 Å crystal structure of Gla-domainless activated protein C, EMBO J. 15(24), 6822 (1996)Google Scholar
  12. 12.
    C.T.Esmon., The regulation of natural anticoagulant pathways, Science 235, 1348 (1997).Google Scholar
  13. 13.
    A.R.Rezaie and C. T. Esman, Tryptophan 231 and 234 in protein C report the Ca2+-dependent conformational change required for activation by the thrombin-thrombomodulin complex, Biochemistry 34, 12221 (1995).PubMedCrossRefGoogle Scholar
  14. 14.
    Sigma Chemical Company (1997): http://www.sigmaaldrich.com.Google Scholar
  15. 15.
    C.T.Esmon., Regulation of coagulation: The nature of the problem, in: Protein C and Related Coagulants, edited by D. F. Bruley and W. N. Drohan (Gulf, Houston, 1990), p. 3.Google Scholar
  16. 16.
    C.I.Fisher., et al., Models of the serine domain of the human antithrombotic plasma factor (1994).Google Scholar
  17. 17.
    D.C.Foster., et al., The nucleotide sequence of the gene for human protein C, Proc. Natl. Acad. Sci. USA 82, 4673 (1985).Google Scholar
  18. 18.
    L.V.Medved., et al., Thermal stability and domain-domain interactions in natural and recombinant protein C, J. Bio. Chem. 270(23), 13659 (1995).Google Scholar
  19. 19.
    C.L.Orthner., et al., Conformational changes in an epitope localized to the NH2-terminal region of protein C, J. Bio. Chem. 2647(31), 18781 (1989).Google Scholar
  20. 20.
    B.W.Grinnell., et al., Trans-activated expression of fully gamma carboxylated recombinant human protein C, an antithrombotic factor, Bio/Technology 5, 1189 (1987).Google Scholar
  21. 21.
    S.C.B.Yan., et al., Post-translational modifications of proteins; some problems left to solve, TIBS 14, 264 (1989).Google Scholar
  22. 22.
    D.F.Bruley., Protein C – The Ultimate Anticoagulant/Antithrombotic?, in: Anticoagulant, Antithrombotic, and Thrombolytic Thearapeutics II, edited by C. A. Thibeault and L. M. Savage (IBC Library Series, Southborough, MA, 1998).Google Scholar
  23. 23.
    H.Wu and D. F. Bruley, Chelator, metal ion and buffer studies for protein C separation, Comparative Biochemistry and Physiology Part A 132, 213 (2002).Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Duane Frederick Bruley
    • 1
  1. 1.Synthesizer, IncEllicott CityUSA

Personalised recommendations